12:00 AM
 | 
Aug 26, 2002
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Abgenix Inc.

(ABGX), Fremont, Calif.

Business: Antibodies

Morgan Stanley analyst Caroline Copithorne lowered her price target to $10 from $12, citing higher risk for...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >